ArticleHepatology communications2022

Inhibition of nonhomologous end joining-mediated DNA repair enhances anti-HBV CRISPR therapy.

Kazuhiro Murai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.